Back to Atlas
CTransientStandard research/education caution
CMP-0264
Investigational
Acolbifene / EM-652
Endocrine / SERM
Breast cancer and endocrine research positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- SERM
- Primary mechanism
- Pure antiestrogenic/tissue-selective ER modulation
- Primary market use
- Oncology / endocrine research
Pharmacology
- Molecular weight (Da)
- 534.7
- Oral bioavailability
- Oral investigational
- Half-life
- Not consistently disclosed
- Route tags
- Route-dependent / verify
- Evidence level
- Clinical
- Clinical status
- Investigational
- Value-for-money score
- 3 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Developmental SERM with limited market access